Satellos Bioscience Inc. (MSLE) Financials

MSLE Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 65.7 million 5.9 million
March 31, 2026 75.5 million 4.6 million
Dec. 31, 2025 31.9 million 4.1 million
Sept. 30, 2025 37.5 million 3.5 million

MSLE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -7.8 million ?
March 31, 2026 -9.5 million 727000
Dec. 31, 2025 -7.3 million 985000
Sept. 30, 2025 -4.1 million 774000

MSLE Net Income

No data available :(

MSLE Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 61.8 million - -
March 31, 2026 70.1 million - -
Dec. 31, 2025 27.7 million - -
Sept. 30, 2025 34.6 million - -

MSLE Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 20.8 million
March 31, 2026 18.4 million
Dec. 31, 2025 15.5 million
Sept. 30, 2025 13.9 million

MSLE Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 21 9.4 million 2.5 million -
March 31, 2026 3946 7.3 million 2.3 million -
Dec. 31, 2025 6 5.5 million 2.0 million -
Sept. 30, 2025 3000 4.0 million 1.9 million -

MSLE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - 974
March 31, 2026 - 986
Dec. 31, 2025 - 1015
Sept. 30, 2025 - 1977

MSLE

Price: $9.55

52 week price:
5.30
13.40

Earnings Per Share: -1.94 USD

Exchange: NGM

Sector: Healthcare

Industry: Medical - Pharmaceuticals

Market Capitalization: 11.6 million

Links: